Comparative effects of idazoxan, prazosin, and yohimbine on coronary ligation-induced arrhythmias in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 2, 1996, Pages 226-234

  Roegel, Jean Christophe ^a   De Jong, Wybren ^a   Monassier, Laurent ^a   Feldman, Josiane ^a   Bousquet, Pascal ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

2 Adrenergic antagonists; Arrhythmia; Coronary artery ligation; Idazoxan; Spontaneously hypertensive rats; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; IDAZOXAN; PANCURONIUM BROMIDE; PRAZOSIN; YOHIMBINE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARRHYTHMIA; CORONARY VESSELS; HEMODYNAMIC PROCESSES; IDAZOXAN; LIGATION; MALE; PRAZOSIN; RATS; RATS, INBRED SHR; YOHIMBINE;

EID: 0030031012     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199602000-00008     Document Type: Article

References (49)

1. Dunn FG, Pringle SD. Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy. J Hypertens 1993;11:1003-10.
2. Beta-Blocker Heart Attack Trial Research Group: a randomized trial of propanolol in patients with acute myocardial infarction. JAMA 1982;247:1717-24.
3. The cardiac arrhythmias suppression trial (CAST) investigators. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
4. The Cardiac Arrhythmias Suppression Trial II Investigators. Effect of the antiarrhythmic agent monicizine on survival after myocardial infarction. N Engl J Med 1992;327:227-33.
5. Yusuf S, Petro R, Lewis J, Collins R. Beta-blockage during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;17:335-71.
6. Bernauer W. Antiarrhythmic and antinecrotic effects of yohimbine stereoisomers in rats during coronary occlusion and reperfusion. Basic Res Cardiol 1990;85:132-41.
7. Deussen A, Busch P, Schipke J, Thämer V, Heusch G. Contribution of postsynaptic alpha2-adrenoceptors to reflex sympathetic constriction of stenotic coronary vessels. Basic Res Cardiol 1990;85(suppl 1): 193-206.
8. Latocha G, Bernauer W. Effect of antiarrhythmic drugs on the postischaemic metabolic recovery of isolated rat hearts. Arch Int Pharmacodyn 1991;312:39-54.
9. Schwartz PJ, Lowell Stone H. Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs. Circ Res 1977;41:51-8.
10. Seitelberger R, Guth BD, Heusch G, Ross J Jr. Alpha2-adrenergic coronary constriction in ischemic myocardium during exercise. In: Heusch G, Ross J Jr, eds. Adrenergic mechanisms in myocardial ischaemia. Darmstadt: Steinkopff Verlag, 1991:207-17.
11. Uprichard AGC, Harron DWG, Wilson R, Shanks RG. Effects of the myocardial-selective alpha1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs. Br J Pharmacol 1988;95:1241-54.
12. Marron DWG, Brezina M. Lillie C, Kobinger W. Antifibrillatory properties of alinidine after coronary artery occlusion in rats. Eur J Pharmacol 1985;110:301-8.
13. Hayashi Y, Sumikawa K, Maze M, et al. Dexmedetomidine prevents epinephrine-induced arrhythmias through stimulation of central alpha2-adrenoceptors in halothaneanesthetized dogs. Anesthesiology 1991;75:113-7.
14. Marshall RJ, Muir AW, Winslow E. Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat. Br J Pharmacol 1981;73:951-9.
15. Curtis MJ, Macleod BA, Walker MJA. Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat. J Mol Cell Cardiol 1987;19:399-419.
16. Wang P, Pfeffer JM, Pfeffer MA. Steinberg CR, Friedman PL. Chronic monitoring of ventricular arrhythmias in conscious spontaneous hypertensive rats. Circulation 1986;74 (suppl II):II74.
17. Yamori Y. Development of the spontaneously hypertensive rat (SHR) and of various spontaneous rat models, and their implications. In: de Jong W, ed. Handbook of hypertension, vol. 4: experimental and genetic models of hypertension. Elsevier Science Publishers B.V., 1984:224-39.
18. Clark C, Foreman MI, Kane KA, McDonald FM, Parratt JR. Coronary artery ligation in anaesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods 1980;3:357-68.
19. Selye H, Bajusz E, Graslo S, Mendell P. Simple technique for the surgical occlusion of coronary vessels in the rat. Angiology 1960;11:398-407.
20. Fabiani JN, Deloche A, Camilleri JP, Joseph D, Carpentier A, Dubost C. Protocole d'étude de l'ischémie aiguë du myocarde chez le rat. Ann Chir Thorac Cardiovasc 1977;16:167-71.
21. Ross J. Electrocardiographic characterisation of myocardial ischaemic injury and infarction. Circulation 1976;53:73-86.
22. Johnston KM, MacLeod BA, Walker MJA. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can J Physiol Pharmacol 1983;61:1340-53.
23. Berlan M, Montastruc JL, Lafontan M. Pharmacological prospects for alpha2-adrenoceptor antagonist therapy. Trends Pharmacol Sci 1992;13:277-82.
24. Bousquet P, Feldman J, Bloch R, Schwartz J. The nucleus reticularis lateralis: a region highly sensitive to clonidine. Eur J Pharmacol 1981;69:389-92.
25. Bousquet P, Feldman J. The blood pressure effects of alpha-adrenoceptor antagonists injected in the medullary site of action of clonidine: the nucleus reticularis lateralis. Life Sci 1987;40:1045-52.
26. Solomon RE, Brody MJ, Gebhart GF. Pharmacological characterisation of alpha-adrenoceptors involved in the antinociceptive and cardiovascular effects of intrathecally administered clonidine. J Pharmacol Exp Ther 1989;251:27-34.
27. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension: man and rat. Circ Res 1981;48:309-19.
28. Walker MJA, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res 1988;22:447-55.
29. Hearse DJ, Richard V, Yellon DM, Kingma JG Jr. Evolving myocardial infarction in the rat in vivo: an inappropriate model for the investigation of drug-induced infarct size limitation during sustained regional ischaemia. J Cardiovasc Pharmacol 1988;11:701-10.
30. Andrejak M, Ward M, Schmitt H. Cardiovascular effects of yohimbine in anaesthetized dogs. Eur J Pharmacol 1983;94:219-28.
31. 1-adrenoceptor blockade during myocardial ischemia and reperfusion in the dog. J Cardiovasc Pharmacol 1985;7(suppl 6):S93-102.
32. Brown MJ, Harland D. Evidence for a peripheral component in the sympatholytic effect of clonidine in rats. Br J Pharmacol 1984;83:657-65.
33. 2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the vogel lick-shock conflict paradigm following intravenous administration. Life Sci 1994;54:179-84.
34. 1-adrenoceptors: an overview. Pharmacol Rev 1993;45:147-75.
35. Berridge TL, Doxey JC, Roach AG, Strachan DA. Comparison of the effects of RX781094 and prazosin on the pressor responses to various alpha-adrenoceptor agonists. Br J Pharmacol 1982;75:140p.
36. 2-adrenoceptors. J Pharmacol 1986;17:113-8.
37. Doxey JC, Lane AC, Roach AG, Virdee NK. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX781094), yohimbine, rauwolscine and corynanthine. Naunyn Schmiedebergs Arch Pharmacol 1984;325:136-44.
38. 2-adrenoceptors. Br J Pharmacol 1983;78:489-505.
39. 2-adrenoceptor blocking properties of (imidazolyl-2)-2-benzodioxane 1,4 (170-150) in pithed rats. Eur J Pharmacol 1981;73:367-70.
40. Reichhalter R, Lillie C, Kobinger W. Effects of alinidine on survival and infarct size in rats with coronary artery occlusion. Eur J Pharmacol 1988;157:75-81.
41. Petty MA, Lukovic L, Grisar JM, Dow J, Bolkenius FN, De Jong W. Myocardial protection by a cardioselective free radical scavenger. Eur J Pharmacol 1994;255:215-222.
42. Parratt JR. Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 1994;15:19-25.
43. Azuma J, Vogel S, Josephson I, Sperelakis N. Yohimbine blockade of ionic channels in myocardial cells. Eur J Pharmacol 1978;51:109-19.
44. 2 alpha in rat aorta. Br J Pharmacol 1983;80:115-21.
45. Kapusta DR, Knardahl S, Koepke JP, Johnson AK, DiBona GF. Selective central alpha-2 adrenoceptor control of regional haemodynamic responses to air jet stress in conscious spontaneously hypertensive rats. J Hypertens 1989;7:189-94.
46. 1-adrenergic system and arrhythmias in ischaemic heart disease. Eur Heart J 1991;12(suppl F):88-98.
47. Starke K. Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 1981;88:199-236.
48. Galitzky J, Rivière D, Tran MA, Montastruc JL, Berlan M. Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers. Eur J Clin Pharmacol 1990;39:447-51.
49. Hendrick G, Vilaine J, Moerman E, Leusen I. Role of prejunctional alpha2-adrenergic receptors in the regulation of myocardial performance during exercise in conscious dogs. Circ Res 1984;14:17-31.